Mirion Technologies, Inc. (NYSE: MIR) is a Industrials company in the Industrial - Machinery industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 175.11 | EPS (ttm) | 0.09 | Insider Own | 33.90% | Shs Outstand | 243.28M | Perf Week | -1.38% |
| Market Cap | 3.83B | Forward P/E | 23.61 | EPS next Y | 0.67 | Insider Trans | 0.01% | Shs Float | 223.97M | Perf Month | 1.03% |
| Enterprise Value | 4.64B | PEG | 9.07 | EPS next Q | 0.12 | Inst Own | - | Short Float | 16.03% | Perf Quarter | -15.31% |
| Income | 25.00M | P/S | 3.74 | EPS this Y | 505.67% | Inst Trans | - | Short Ratio | 9.06 | Perf Half Y | -19.96% |
| Sales | 1.02B | P/B | 2.04 | EPS next Y | 22.45% | ROA | 0.70% | Short Interest | 35.91M | Perf YTD | -32.71% |
| Book/sh | 7.71 | P/C | 9.02 | EPS next 5Y | 19.31% | ROE | 1.33% | 52W High | 30.28 -47.95% | Perf Year | -30.57% |
| Cash/sh | 1.75 | P/FCF | 28.42 | EPS past 3/5Y | - | ROIC | 1.41% | 52W Low | 14.11 11.69% | Perf 3Y | 107.10% |
| Dividend Est. | - | EV/EBITDA | 21.46 | Sales past 3/5Y | 8.81% - | Gross Margin | 48.00% | Volatility | 4.54% 4.11% | Perf 5Y | 56.97% |
| Dividend TTM | - | EV/Sales | 4.52 | EPS Y/Y TTM | 150.00% | Oper. Margin | 5.32% | ATR (14) | 0.71 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.63 | Sales Y/Y TTM | 19.05% | Profit Margin | 2.39% | RSI (14) | 49.62 | Recom | 2.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.20 | EPS Q/Q | 9.09% | SMA20 | 0.88% | Beta | 1.08 | Target Price | 23.60 |
| Payout | 0.00% | Debt/Eq | 0.64 | Sales Q/Q | 19.73% | SMA50 | 0.08% | Rel Volume | 1.88 | Prev Close | 16.24 |
| Employees | 3,281 | LT Debt/Eq | 0.64 | Earnings | Oct 27 | SMA200 | -19.71% | Avg Volume | 3.99M | Price | 15.76 |
| IPO Date | Aug 20, 2020 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 16.03% -0.93% | Net Debt/EBITDA | 3.78 | Volume | 7,502,132 | Change | -2.96% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-03-26 | Initiated | Jefferies | Buy | $20 |
| Aug-10-26 | Reiterated | Morgan Stanley | Equal Weight | $25 → $23 |
| Jul-30-26 | Reiterated | Northland Securities | Outperform | $29 → $24 |
| Jul-29-26 | Reiterated | Goldman Sachs | Buy | $25 → $23 |
| Jul-13-26 | Reiterated | Morgan Stanley | Equal Weight | $27 → $25 |
| Jul-10-26 | Reiterated | Goldman Sachs | Buy | $29 → $25 |
| May-04-26 | Reiterated | Evercore ISI Group | Outperform | $29 → $28 |
| Mar-11-26 | Reiterated | Morgan Stanley | Equal Weight | $29 → $27 |
| Feb-13-26 | Reiterated | Robert W. Baird | $30 → $29 | |
| Feb-12-26 | Reiterated | Goldman Sachs | Buy | $34 → $29 |
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 6/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,025 | 925 | 861 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 534 | 487 | 459 | — | — | — | — | — | — | |
| Gross Profit | 492 | 439 | 402 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 398 | 348 | 338 | — | — | — | — | — | — | |
| Research and Development | 40 | 39 | 35 | — | — | — | — | — | — | |
| Other Operating Expense | -1 | 0 | 4 | — | — | — | — | — | — | |
| Operating Income | 55 | 52 | 25 | — | — | — | — | — | — | |
| Interest Expense | 34 | 42 | 58 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 12 | 23 | -1 | — | — | — | — | — | — | |
| Net Income Before Taxes | 30 | 33 | -34 | — | — | — | — | — | — | |
| Income Taxes | 4 | 3 | 3 | — | — | — | — | — | — | |
| Consolidated Net Income | 25 | 29 | -36 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 26 | 30 | -37 | — | — | — | — | — | — | |
| Net Income | 25 | 29 | -36 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.10 | 0.13 | -0.18 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.10 | 0.13 | -0.18 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.09 | 0.11 | -0.18 | — | — | — | — | — | — | |
| EBITDA | 216 | 213 | 179 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 175.11 | 212.91 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.77 | 5.82 | 4.15 | — | — | — | — | — | — | |
| Gross Margin | 48.00 | 47.46 | 46.69 | — | — | — | — | — | — | |
| Operating Margin | 5.37 | 5.62 | 2.90 | — | — | — | — | — | — | |
| Net Margin | 2.44 | 3.14 | -4.18 | — | — | — | — | — | — | |
| Shares Outstanding | 245 | 230 | 205 | — | — | — | — | — | — | |
| Market Capitalization | 3,861 | 5,387 | 3,577 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Schopfer Brian | Chief Financial Officer | Sep 02 '26 | Buy | 15.60 | 20,000 | 312,000 | 933,290 | Sep 02 |
| Moore Christopher A. | Chief Accounting Officer (PAO) | May 07 '26 | Sale | 19.64 | 8,400 | 164,976 | 22,157 | May 08 |
| Kingsley Lawrence D | Director | Dec 10 '25 | Sale | 24.73 | 350,000 | 8,654,800 | 3,509,075 | Dec 12 |
| Kingsley Lawrence D | Director | Nov 21 '25 | Sale | 23.83 | 300,000 | 7,148,400 | 3,900,000 | Nov 21 |
| Eloy Loic | Nuclear & Safety President | Nov 11 '25 | Sale | 27.24 | 45,000 | 1,225,683 | 97,770 | Nov 12 |
| Lee Emmanuelle | Chief Legal Officer | Nov 10 '25 | Sale | 27.41 | 12,500 | 342,643 | 84,640 | Nov 12 |
| Schopfer Brian | Chief Financial Officer | Nov 06 '25 | Sale | 27.65 | 100,000 | 2,765,420 | 904,432 | Nov 10 |
| Logan Thomas D | Chief Executive Officer | Aug 12 '25 | Sale | 21.79 | 175,000 | 3,813,635 | 3,567,305 | Aug 13 |
| Logan Thomas D | Chief Executive Officer | Aug 11 '25 | Sale | 21.31 | 325,000 | 6,927,148 | 3,742,305 | Aug 13 |
| Eloy Loic | Nuclear & Safety President | Aug 05 '25 | Sale | 21.30 | 22,166 | 472,138 | 142,770 | Aug 06 |
| Schopfer Brian | Chief Financial Officer | Jun 25 '25 | Sale | 21.00 | 75,000 | 1,575,000 | 919,432 | Jun 27 |
| Kingsley Lawrence D | Director | May 21 '25 | Sale | 17.94 | 500,000 | 8,972,350 | 0 | May 23 |
| Schopfer Brian | Chief Financial Officer | May 21 '25 | Sale | 18.27 | 75,000 | 1,370,003 | 919,432 | May 23 |
| Eloy Loic | Technologies Group President | Dec 13 '24 | Sale | 17.89 | 44,000 | 787,160 | 133,663 | Dec 17 |
| Lee Emmanuelle | Chief Legal Officer | Oct 31 '24 | Sale | 14.27 | 3,405 | 48,603 | 0 | Nov 04 |